David Germonpré
Director/Board Member bij InOpSys NV
Profiel
David Germonpré is currently a Director at Blueprint Genetics Oy, a Director at InOpSys NV, a Director at FOx Biosystems NV, and a Partner at MTIP AG.
He previously worked as a Director at MAGICS Technologies NV and as an Investment Manager at Gemma Frisius Fonds K.U.
Leuven from 2013 to 2019.
Actieve functies van David Germonpré
Bedrijven | Functie | Begin |
---|---|---|
InOpSys NV
InOpSys NV Industrial MachineryProducer Manufacturing InOpSys NV develops treatments for hazardous wastewater. It designs and delivers flexible, modular and mobile units. The company was founded by Raf Dewil and Lies Appels and is headquartered in Mechelen, Belgium. | Director/Board Member | - |
FOx Biosystems NV
FOx Biosystems NV Packaged SoftwareTechnology Services FOx Biosystems NV engages in the provision of life science research tool. It offers White Fox 1.0, a surface plasmon resonance biosensor technology. Its services include evaluation and system support and development of custom applications and devices. The company was founded by Filip Delport and Jeroen Lammertyn in 2016 and is headquartered in Temse, Belgium. | Director/Board Member | - |
MTIP AG
MTIP AG Investment ManagersFinance MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland. | Private Equity Investor | 01-01-2019 |
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Director/Board Member | 01-02-2019 |
Eerdere bekende functies van David Germonpré
Bedrijven | Functie | Einde |
---|---|---|
Gemma Frisius Fonds K.U. Leuven
Gemma Frisius Fonds K.U. Leuven Investment ManagersFinance Gemma Frisius Fonds K.U. Leuven (GFF) is an Independent Venture Capital firm founded in 1997 as a joint venture between Katholieke Universiteit Leuven, KBC Group and BNP Paribas Group. Gemma Frisius K.U. Leuven is headquartered in Leuven. | Private Equity Investor | 01-01-2019 |
MAGICS Technologies NV
MAGICS Technologies NV Electronic Production EquipmentElectronic Technology MAGICS Instruments NV develops and sells radiation-tolerant electronic circuits for the nuclear industry. It provides MGy-level radiation services on its products or other commercial-of-the-shelf components. The company was founded by Cao Ying and Jens Verbeek on October 28, 2015 and is headquartered in Mol, Belgium. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
Gemma Frisius Fonds K.U. Leuven
Gemma Frisius Fonds K.U. Leuven Investment ManagersFinance Gemma Frisius Fonds K.U. Leuven (GFF) is an Independent Venture Capital firm founded in 1997 as a joint venture between Katholieke Universiteit Leuven, KBC Group and BNP Paribas Group. Gemma Frisius K.U. Leuven is headquartered in Leuven. | Finance |
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Health Technology |
MAGICS Technologies NV
MAGICS Technologies NV Electronic Production EquipmentElectronic Technology MAGICS Instruments NV develops and sells radiation-tolerant electronic circuits for the nuclear industry. It provides MGy-level radiation services on its products or other commercial-of-the-shelf components. The company was founded by Cao Ying and Jens Verbeek on October 28, 2015 and is headquartered in Mol, Belgium. | Electronic Technology |
InOpSys NV
InOpSys NV Industrial MachineryProducer Manufacturing InOpSys NV develops treatments for hazardous wastewater. It designs and delivers flexible, modular and mobile units. The company was founded by Raf Dewil and Lies Appels and is headquartered in Mechelen, Belgium. | Producer Manufacturing |
MTIP AG
MTIP AG Investment ManagersFinance MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland. | Finance |
FOx Biosystems NV
FOx Biosystems NV Packaged SoftwareTechnology Services FOx Biosystems NV engages in the provision of life science research tool. It offers White Fox 1.0, a surface plasmon resonance biosensor technology. Its services include evaluation and system support and development of custom applications and devices. The company was founded by Filip Delport and Jeroen Lammertyn in 2016 and is headquartered in Temse, Belgium. | Technology Services |